Stocks and Investing
Stocks and Investing
Mon, May 6, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, May 3, 2024
[ 12:00 AM ] - United States, WOPRAI
Eric Coldwell Maintained (CAH) at Buy with Decreased Target to $128 on, May 3rd, 2024
Eric Coldwell of Baird, Maintained "Cardinal Health, Inc." (CAH) at Buy with Decreased Target from $134 to $128 on, May 3rd, 2024.
Eric has made no other calls on CAH in the last 4 months.
There are 5 other peers that have a rating on CAH. Out of the 5 peers that are also analyzing CAH, 0 agree with Eric's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Eric
- Stephen Baxter of "Wells Fargo" Maintained at Sell with Decreased Target to $94 on, Monday, April 29th, 2024
- Michael Cherny of "Leerink Partners" Initiated at Buy and Held Target at $125 on, Monday, February 26th, 2024
- David Toung of "Argus Research" Upgraded from Hold to Strong Buy on, Friday, February 9th, 2024
- Kevin Caliendo of "UBS" Maintained at Strong Buy with Increased Target to $125 on, Monday, February 5th, 2024
- Stephanie Davis of "Barclays" Initiated at Buy and Held Target at $117 on, Wednesday, January 3rd, 2024
Contributing Sources